Probiotic Limosilactobacillus reuteri KUB-AC5 decreases urothelial cell invasion and enhances macrophage killing of uropathogenic Escherichia coli in vitro study

IntroductionBacterial urinary tract infections (UTI) are among the most common infectious diseases worldwide. The rise of multidrug-resistant (MDR) uropathogenic Escherichia coli (UPEC) UTI cases is a significant threat to healthcare systems. Several probiotic bacteria have been proposed as an alter...

Descrición completa

Detalles Bibliográficos

Principais autores:	Arishabhas Tantibhadrasapa, Songbo Li, Songphon Buddhasiri, Chutikarn Sukjoi, Panupon Mongkolkarvin, Pattarapon Boonpan, Somsakul Pop Wongpalee, Prasobsook Paenkaew, Sawannee Sutheeworapong, Massalin Nakphaichit, Sunee Nitisinprasert, Michael H. Hsieh, Parameth Thiennimitr
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-07-01
Series:	Frontiers in Cellular and Infection Microbiology
Assuntos:	uropathogenic E. coli (UPEC) urinary tract infection (UTI) probiotic Limosilactobacillus reuteri immune modulation immunobiotic
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fcimb.2024.1401462/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!